Oroes (Escitalopram)

Escitalopram, the active ingredient in Oroes, is a selective serotonin reuptake inhibitor presented as a tablet for oral use. It is commonly prescribed for major depressive disorder and generalized anxiety disorder in adults. GNH USA supplies Oroes as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oroes as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Escitalopram is a selective serotonin reuptake inhibitor that acts on mood‑regulating pathways. - Major Depressive Disorder: Improves depressive symptoms and functional outcomes. - Generalized Anxiety Disorder: Reduces anxiety symptoms and associated distress. - Social Anxiety Disorder: Alleviates social fear and avoidance behaviors. - Panic Disorder: Decreases frequency and severity of panic attacks.

Side effects vary in frequency and severity.

Common Side Effects: - Nausea - Headache - Insomnia - Dry mouth - Increased sweating - Fatigue

Serious or Rare Side Effects: - Suicidal thoughts or behavior - Serotonin syndrome - Severe allergic reaction (anaphylaxis) - QT interval prolongation - Abnormal heart rhythm (arrhythmia)

When prescribing Escitalopram, clinicians should consider several safety aspects. - Pregnancy: Use only if the potential benefit outweighs the risk. - Breastfeeding: Assess infant risk versus maternal benefit. - Elderly patients: Start with a lower dose and monitor for hyponatremia. - Concomitant serotonergic drugs: Monitor for serotonin syndrome. - Discontinuation: Taper gradually to reduce withdrawal symptoms. - Store at below 20°C: keep in original packaging.

Store at below  ??